Dr. Cheng is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1825 4th St
Fl 6
San Francisco, CA 94143Phone+1 415-885-3882
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2015 - 2018
University of California (San Francisco)Residency, Internal Medicine, 2012 - 2015
David Geffen School of Medicine at UCLAClass of 2012
Certifications & Licensure
CA State Medical License 2013 - 2026
MA State Medical License 2018 - 2023- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Niraparib in Combination With Osimertinib in EGFR-Mutated Advanced Lung Cancer Start of enrollment: 2019 Jun 06
Roles: Contact, Principal Investigator
- Plasma-Adapted First-Line Pembro In NSCLC Start of enrollment: 2020 Jan 13
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- A Translational Study of the ATR Inhibitor Berzosertib as Monotherapy in Four Molecularly Defined Cohorts of Advanced Solid Tumors.Gregory M Cote, Bose S Kochupurakkal, Khanh Do, Andrea Bullock, Michael L Cheng
Clinical Cancer Research. 2025-01-06 - Associations of frailty with survival, hospitalization, functional decline, and toxicity among older adults with advanced non-small cell lung cancer.Howard J Lee Jr, John Boscardin, Louise C Walter, Alexander K Smith, Harvey J Cohen
The Oncologist. 2024-12-09 - 3 citationsInitial Chemotherapy for Locally Advanced and Metastatic NUT Carcinoma.Jia Luo, Michelle Sanchez, Elinton Lee, Hans Hertzler, Nhi Luong
Journal of Thoracic Oncology. 2024-05-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
